IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Actavis Expands into New Markets; May Enter Biosimilars

8:29 AM MDT | October 30, 2009 | Deepti Ramesh in Madrid

Generic pharmaceuticals producer Actavis (Hafnarfjordur, Iceland) says it is expanding its presence in regions such as Japan, the Mideast, and South America. The company is also monitoring closely the biosimilars market and related activities within the sector. Actavis, which is not currently involved in the biosimilars business, is considering entering the market by establishing joint ventures or partnerships, Stefan Sveinsson, executive v.p./R&D at Actavis, told CW at the CPhI expo, held last month in Madrid. Actavis says that biosimilars will play a major...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.


Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis from the entire global chemical enterprise on chemweek.com
  • Mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa